Sentences with phrase «identified by developing country»

The current draft of the agreement includes the option that new money should be provided after 2020 «in line with needs and priorities identified by developing country Parties».

Its strategy consists of four key components: 1) Priority identification — we respond to the crop biotechnology needs and priorities identified by developing countries; 2) Technology appraisal — we work to identify, evaluate, and facilitate the acquisition of new crop biotechnology applications; 3) Project implementation — we implement a portfolio of crop biotechnology projects that have a potential for near - term impact in food, feed, fiber crops, and forestry; and 4) Services for the enabling environment — we provide advice and services to assist in the development of an enabling environment to support the safe application of crop biotechnology.

Not exact matches

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

- A new specialist FGM service which will include social services, to proactively identify and respond to FGM; this will be supported by an ongoing package of work led by the Chief Social Worker Isabelle Trowlernew programmes to prevent child and forced marriage in 12 developing countries

By developing blood biomarkers and «immunologic signatures» related to antigen - specific T - cell responses, the researchers hope to identify individuals with latent TB infection who are at greatest risk for progression to active disease, allowing development of prevention strategies to target those at highest risk in areas with high rates of infection (usually low - and middle - income countries), as well as high income countries such as the U.S., where factors such as recent infection and HIV co-infection are associated with an increased risk of progression to active TB.

It will fund research aimed at reducing the number of infant deaths from neonatal sepsis in developing countries by identifying the roots of infection, from season of birth to home environment.

In a consortium led by the Finnish consultancy GAIA and with the Stockholm Environment Institute (SEI), NewClimate Institute carried out a study on behalf of the Nordic Working Group for Global Climate Negotiations (NOAK) to identify how Nordic finance institutions can best contribute to mobilising climate finance to developing countries in a way that supports the implementation of the Paris Agreement.

Developing new teacher - evaluation systems has been identified by scholars and policymakers alike as a crucial part of improving teacher quality and raising student academic performance across the country.

At the same time, the unrelenting rise in greenhouse - gas emissions in developing countries is propelled by an unbending reality identified way back in 2005 by British Prime Minister Tony Blair, when he said, «The blunt truth about the politics of climate change is that no country will want to sacrifice its economy in order to meet this challenge.»

Thank you for downloading the «Climate Change Mitigation Opportunities Index», developed by The EIU with the Morgan Stanley Institute for Sustainable Investing, is a starting point for investors to identify in - country investment opportunities in climate change mitigation technology.

The idea was to identify activities that developing countries could undertake to earn credit by reducing emissions, and REDD clearly fit into that category.

In conclusion, we have identified strong ethical arguments that support the need to ramp up non-fossil fuel combustion in the United States and other developed countries while implicitly acknowledging that there could be some short - term benefit if coal combustion is replaced by natural gas, a conclusion that only can be reached with better understanding of the methane leakage issues.

The paper identifies several major themes among the alternative proposals: Kyoto is «too little, too fast»; developing countries should play a more substantial role and receive incentives to participate; implementation should focus on market - based approaches, especially those with price mechanisms; and participation and compliance incentives are inadequately addressed by most proposals.

This report was drafted by a working group of United Nations entities, the World Bank, and other stakeholders to suggest a common understanding of the blue economy; to highlight the importance of such an approach, particularly for small island developing states and coastal least developed countries; to identify some of the key challenges its adoption poses; and to suggest some broad next steps that are called for in order to ensure its implementation.

The logical next step is to identify efficacious and cost - effective health services interventions that can tackle the all - important «so - what» question that is posed by doctors and policy makers in developing countries when confronted with startling prevalence statistics.

First that the process of identifying the group gives confidence to Indigenous people by reflecting the traditional ways of defining who has rights to country, and second, that it gives confidence to those seeking to develop productive partnerships with traditional owners that their dealings and investments will not be undermined in the future by claims from other groups and individuals.